181 related articles for article (PubMed ID: 6816682)
1. Biochemical and immunological characteristics of acute lymphoblastic leukemia.
Abbadessa V; Citarrella P; Di Marco P; Cajozzo C; Perricone R; Prezioso A; Cajozzo A
Haematologica; 1982 Oct; 67(5):702-9. PubMed ID: 6816682
[No Abstract] [Full Text] [Related]
2. [The heterogeneity of human lymphoid leukemias unmasked by immunological studies of membrane markers (author's transl)].
Seligmann M; Brouet JC; Preud'homme JL
Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):339-50. PubMed ID: 303356
[TBL] [Abstract][Full Text] [Related]
3. [Immunobiological features of acute lymphoblastic leukaemia].
Gavosto F
Haematologica; 1983; 68(1):1-19. PubMed ID: 6404699
[No Abstract] [Full Text] [Related]
4. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
Zipf TF; Fox RI; Dilley J; Levy R
Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Unmasking the heterogeneity of acute lymphoblastic leukemia.
Gelfand EW; Chechik BE
N Engl J Med; 1976 Jan; 294(5):275-6. PubMed ID: 1081642
[No Abstract] [Full Text] [Related]
6. [Cytochemical characteristics and immunologic markers in acute lymphoblastic leukemias (author's transl)].
Dorlhiac P; Genter G; Jamra M
Sangre (Barc); 1981; 26(4):433-8. PubMed ID: 6974901
[No Abstract] [Full Text] [Related]
7. Immunological and molecular classification of acute lymphoblastic leukemia.
Foa R; Migone N; Gavosto F
Haematologica; 1986; 71(4):277-85. PubMed ID: 3096821
[No Abstract] [Full Text] [Related]
8. [Lymphoblastic leukemia and immunological markers].
Ifrah N; Perrot JY; Marie JP; Boasson M; Zittoun R
Ann Med Interne (Paris); 1987; 138(7):527-32. PubMed ID: 3326452
[TBL] [Abstract][Full Text] [Related]
9. [Immunological and clinical differences between lymphoblastic leukemia and lymphoma originating from non-T, non-B cells, T cells and B cells].
Rupniewska ZM; Kniaź M
Postepy Hig Med Dosw; 1980; 34(2):119-41. PubMed ID: 7017639
[No Abstract] [Full Text] [Related]
10. [Clinical immunological characteristics of the B-variant of chronic lympholeukemia].
Turusova VK; Il'in NV; Letskiĭ VB
Ter Arkh; 1978; 50(10):112-4. PubMed ID: 309184
[No Abstract] [Full Text] [Related]
11. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
Greaves MF
Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
[TBL] [Abstract][Full Text] [Related]
12. B-cell markers on lymphoblasts in acute lymphoblastic leukaemia.
Gajl-Peczalska KJ; Bloomfield CD; Nesbit ME; Kersey JH
Clin Exp Immunol; 1974 Aug; 17(4):561-9. PubMed ID: 4219600
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte ecto-5'-nucleotidase activity as a marker of B-cell maturation.
Boss GR; Thompson LF; Spiegelberg HL; Waldmann TA; O'Connor RD; Hamburger RN; Seegmiller JE
Trans Assoc Am Physicians; 1979; 92():309-15. PubMed ID: 232944
[No Abstract] [Full Text] [Related]
14. [Characteristics of acute lymphoblastic leukemia of children with 0-cells in the bone marrow and a predominance of T- or B-cells in the peripheral blood].
Lenskaia RV; Samochatova EV; Rumiantsev AG; Izotova TA
Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):20-4. PubMed ID: 6974356
[No Abstract] [Full Text] [Related]
15. S IgA on blast cells in acute lymphoblastic leukemia.
Formisano S; De Renzo A; Catalano L; Cosentini E; Rotoli B
Haematologica; 1982 Aug; 67(4):611-8. PubMed ID: 6815020
[No Abstract] [Full Text] [Related]
16. [Surface markers of T and B lymphocytes: I. General view and acute lymphoblastic leukaemia (ALL) (author's transl)].
Tomić BL
Lijec Vjesn; 1980 Nov; 102(11):643-6. PubMed ID: 7024694
[No Abstract] [Full Text] [Related]
17. B cell acute lymphoblastic leukemia (ALL) associated with alterations in surface and biochemical markers.
Kano Y; Sakamoto S; Takaku F; Hida K; Kasahara T; Shimoyama M
Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):221-4. PubMed ID: 6602451
[No Abstract] [Full Text] [Related]
18. Immunobiological classification of acute lymphoblastic leukaemia (ALL).
Gavosto F; Ferrarini M; Caligaris Cappio F; Foa R
Prog Clin Biol Res; 1983; 132D():431-44. PubMed ID: 6605537
[No Abstract] [Full Text] [Related]
19. [Indicators of cellular immunity and the incidence of infectious-inflammatory diseases during clinico-hematological remission in patients with acute leukemia].
Vinogradova IuE; Ivanina EK
Ter Arkh; 1984; 56(6):46-50. PubMed ID: 6332389
[No Abstract] [Full Text] [Related]
20. [Immunologic phenotype of acute leukemia, with reference to FAB classification of acute leukemia].
Shimoyama M; Minato K; Tobinai K; Hirose M
Rinsho Ketsueki; 1982 Jul; 23(7):1019-29. PubMed ID: 6982980
[No Abstract] [Full Text] [Related]
[Next] [New Search]
